TapewireFind a company

person · Reporting owner

Petras Michael B. Jr.

Disclosed activity across 1 company

Tapewire entity
21490
SEC CIK
0001832387

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Sotera Health CoSHC · Entity 3869Director · Executive ChairmanAugust 17, 2026August 19, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Sotera Health Co

Report date August 17, 2026 · Filed August 19, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivativeDirect397,912 Reported balance After 2026-08-17 transaction · row 1
1 source row

Row 1 · 2026-08-17 · Sale · Disposed 294,515 · Balance 397,912

F1: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Common StockSEC Table I · non-derivativeIndirectBy Grantor Trust3,969,393 Reported balance After 2026-08-17 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2026-08-17 · Sale · Disposed 850,000 · Balance 3,969,393

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Filing footnotes · ownership attribution and instrument terms

F1: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2026 Filed Aug 19, 2026 20:24 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock 850,000 $18.50 $15,725,935.00
Disclosure

SEC source: 0001193125-26-356962 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 3,969,393

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 20:24 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock, $0.01 par value per share ("Common Stock") 294,515 $18.50 $5,448,851.47
Disclosure

SEC source: 0001193125-26-356962 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,912

F1 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.50 - $18.855. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 GrantShare Appreciation Units · Derivative 120,124 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · derivative · entry 9

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,124

Underlying: Common Stock · 120,124 shares

Expires not disclosed

F7 · derivative.exercise_price: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.

F7 · derivative.exercise_date: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.

F7 · derivative.expiration_date: These securities consist of a maximum number of SAUs that were granted on March 2, 2026, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related peformance conditions. The SAUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Exercise / conversionShare Appreciation Units · Derivative 89,686 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · derivative · entry 8

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,790

Underlying: Common Stock · 89,686 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

F3 · price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

F3 · derivative.exercise_date: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

F3 · derivative.expiration_date: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock 240,248 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 6

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 692,427

F6 · shares: These securities consist of RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 2027.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock 79,104 $15.91 $1,258,544.64
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 5

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 452,179

F5 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 179,372 RSUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock 39,552 $15.91 $629,272.32
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 4

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 531,283

F4 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 89,686 SAUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represents the Reporting Person's right to recieve one share of Common Stock, subject to performance.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Exercise / conversionCommon Stock 89,686 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 570,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

F3 · price: These securities consist of performance-based share appreciation units ("SAUs") (formerly called performance stock units) that were granted on March 3, 2025, pursuant to the terms of a SAU Agreement under the 2020 Incentive Plan. Each SAU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the SAUs, the Reporting Person vested in 89,686 shares of Common Stock on March 2, 2026. The remaining SAUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock 40,302 $15.91 $641,204.82
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,149

F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 91,386 RSUs granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 02:17 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 31,339 $15.91 $498,603.49
Disclosure

SEC source: 0001193125-26-092231 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 521,451

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 Restricted Stock Units ("RSUs") granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:43 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock 39,243 $16.45 $645,547.35
Disclosure

SEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 0

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:43 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock 394,861 $16.45 $6,495,463.45
Disclosure

SEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 4,819,393

Read SEC document
December 08, 2025 Filed Dec 10, 2025 21:43 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock, $0.01 par value per share ("Common Stock") 315,896 $16.45 $5,196,489.20
Disclosure

SEC source: 0001193125-25-314343 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 552,790

Read SEC document
March 03, 2025 Filed Mar 5, 2025 02:49 UTC Sotera Health Co SHC · Entity 3869 GrantPerformance Stock Units · Derivative 149,476 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032994 · ownership.xml · derivative · entry 7

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,476

Underlying: Common Stock · 149,476 shares

Expires not disclosed

F7 · derivative.exercise_price: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

F7 · shares: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

F7 · derivative.exercise_date: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

F7 · derivative.expiration_date: These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 02:49 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock 298,953 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 4

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 868,603

F4 · shares: These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026.

F5 · balance_after: These securities consist of 552,790 RSUs and 315,813 shares of Common Stock.

Read SEC document
March 02, 2025 Filed Mar 5, 2025 02:49 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock 40,987 $12.47 $511,107.89
Disclosure

SEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 569,650

F3 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 91,386 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.

Read SEC document
March 02, 2025 Filed Mar 5, 2025 02:49 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock 31,872 $12.47 $397,443.84
Disclosure

SEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 610,637

F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Read SEC document
March 02, 2025 Filed Mar 5, 2025 02:49 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 27,990 $12.47 $349,035.30
Disclosure

SEC source: 0000950170-25-032994 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 642,509

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,407 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Read SEC document
November 22, 2024 Filed Nov 22, 2024 22:50 UTC Sotera Health Co SHC · Entity 3869 GiftCommon Stock, $0.01 par value per share ("Common Stock") 39,243 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Family Trust

Disclosed balance after: 39,243

F3 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
November 22, 2024 Filed Nov 22, 2024 22:50 UTC Sotera Health Co SHC · Entity 3869 GiftCommon Stock, $0.01 par value per share ("Common Stock") 39,243 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 5,214,337

Read SEC document
November 20, 2024 Filed Nov 22, 2024 22:50 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 29,250 $13.21 $386,392.50
Disclosure

SEC source: 0000950170-24-130309 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670,499

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

F2 · balance_after: These securities consist of 478,693 RSUs and 191,806 shares of Common Stock.

Read SEC document
September 10, 2024 Filed Sep 12, 2024 20:18 UTC Sotera Health Co SHC · Entity 3869 GiftCommon Stock, $0.01 par value per share ("Common Stock") 200,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-105933 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 5,253,580

F1 · shares: Represents a gift of issuer securities by the reporting person to a charitable foundation. The recipient of the gifted securities has executed a lock-up agreement equivalent to the lock-up agreement entered into with respect to the September 6, 2024 registered stock offering.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:35 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 544,509 $0.00 Strike: $14.59 $0.00
Disclosure

SEC source: 0000950170-24-026347 · ownership.xml · derivative · entry 5

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544,509

Underlying: Common Stock · 544,509 shares

Expires 2034-03-04

F7 · derivative.exercise_date: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.

F7 · balance_after: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:35 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock, $0.01 par value per share ("Common Stock") 1,003,870 $14.31 $14,362,870.03
Disclosure

SEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 4

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 5,453,580

F5 · shares: On March 4, 2024, the Reporting Person sold a total of 1,003,870 shares of Common Stock of the Issuer in an underwritten public secondary offering (the "Offering").

F6 · price: Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the Issuer's Prospectus 424(b)(7), filed with the United States Securities and Exchange Commission on February 29, 2024.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 22:35 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 274,160 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 699,749

F3 · shares: These securities consist of RSUs that were granted on March 4, 2024, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2025.

F4 · balance_after: These securities consist of 543,910 RSUs and 155,839 shares of Common Stock.

Read SEC document
March 02, 2024 Filed Mar 5, 2024 22:35 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 21,574 $14.56 $314,117.44
Disclosure

SEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,589

F2 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Read SEC document
March 02, 2024 Filed Mar 5, 2024 22:35 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 27,990 $14.56 $407,534.40
Disclosure

SEC source: 0000950170-24-026347 · ownership.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 447,163

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,406 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 21:08 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 29,250 $13.93 $407,452.50
Disclosure

SEC source: 0001822479-23-000070 · wk-form4_1700687309.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 555,418

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

F2 · price: Represents the closing price of the Company's Common Stock on November 20, 2023.

F3 · balance_after: These securities consist of 403,219 RSUs and 152,199 shares of Common Stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:35 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 404,094 $0.00 Strike: $17.59 $0.00
Disclosure

SEC source: 0001822479-23-000021 · wf-form4_167831492828392.xml · derivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,094

Underlying: Common Stock · 404,094 shares

Expires 2033-03-06

F4 · derivative.exercise_date: These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions.

F4 · balance_after: These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:35 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 213,189 $0.00 $0.00
Disclosure

SEC source: 0001822479-23-000021 · wf-form4_167831492828392.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 584,668

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 6, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2024.

F2 · balance_after: These securities consist of 468,436 RSUs and 116,232 shares of Common Stock.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 23:47 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 19,841 $17.41 $345,431.81
Disclosure

SEC source: 0001822479-23-000017 · wf-form4_167814642447695.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 371,479

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,406 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

F2 · price: Represents the closing price of the Company's Common Stock on March 2, 2023.

F3 · balance_after: These securities consist of 255,247 RSUs and 116,232 shares of Common Stock.

Read SEC document
November 20, 2022 Filed Nov 22, 2022 22:00 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 29,251 $6.02 $176,091.02
Disclosure

SEC source: 0001822479-22-000080 · wf-form4_166915442637925.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,320

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,218 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

F2 · price: Represents the closing price of the Company's Common Stock on November 18, 2022.

F3 · balance_after: These securities consist of 317,653 RSUs and 73,667 shares of Common Stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 22:20 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 2,108,356 $0.00 Strike: $6.37 $0.00
Disclosure

SEC source: 0001822479-22-000078 · wf-form4_166803242535825.xml · derivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,108,356

Underlying: Common Stock · 2,108,356 shares

Expires 2032-11-07

F3 · derivative.exercise_date: These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date.

F3 · balance_after: These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:13 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 478,932 $0.00 Strike: $20.03 $0.00
Disclosure

SEC source: 0001822479-22-000019 · wf-form4_164642836722086.xml · derivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 478,932

Underlying: Common Stock · 478,932 shares

Expires 2032-03-02

F4 · derivative.exercise_date: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F4 · balance_after: These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 21:13 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 187,219 $0.00 $0.00
Disclosure

SEC source: 0001822479-22-000019 · wf-form4_164642836722086.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,571

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

F2 · balance_after: These securities consists of 382,871 RSUs and 37,700 shares of Common Stock.

Read SEC document
November 20, 2021 Filed Nov 24, 2021 01:00 UTC Sotera Health Co SHC · Entity 3869 Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") 27,517 $22.54 $620,233.18
Disclosure

SEC source: 0001822479-21-000076 · wf-form4_163771559892577.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,352

F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

F2 · balance_after: These securities consists of 195,652 RSUs and 37,700 shares of Common Stock.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 20:34 UTC Sotera Health Co SHC · Entity 3869 SaleCommon Stock, $0.01 par value per share ("Common Stock") 817,439 $26.12 $21,353,550.28
Disclosure

SEC source: 0001628280-21-005471 · wf-form4_161661805855061.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 6,377,185

F1 · shares: On March 22, 2021, Mr. Petras sold a total of 817,439 shares of Common Stock of Sotera Health Company in an underwritten public secondary offering (the "Offering").

F2 · price: Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Prospectus 424(b)(4), filed with the United States Securities and Exchange Commission on March 18, 2021.

Read SEC document
November 24, 2020 Filed Nov 24, 2020 23:56 UTC Sotera Health Co SHC · Entity 3869 Disposition to issuerCommon Stock 946,102 $21.68 $20,511,491.36
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 3

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Grantor Trust

Disclosed balance after: 7,194,624

F2 · price: Reflects a company repurchase price equal to the initial public offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Registration Statement on Form S-1.

Read SEC document
November 24, 2020 Filed Nov 24, 2020 23:56 UTC Sotera Health Co SHC · Entity 3869 Disposition to issuerCommon Stock 437,821 $21.68 $9,491,959.28
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 2

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Grantor Retained Annuity Trust

Disclosed balance after: 0

F2 · price: Reflects a company repurchase price equal to the initial public offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the company's Registration Statement on Form S-1.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:56 UTC Sotera Health Co SHC · Entity 3869 GrantStock Options · Derivative 1,118,012 $0.00 Strike: $23.00 $0.00
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · derivative · entry 4

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,118,012

Underlying: Common Stock · 1,118,012 shares

Expires 2030-11-20

F3 · derivative.exercise_date: These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document
November 20, 2020 Filed Nov 24, 2020 23:56 UTC Sotera Health Co SHC · Entity 3869 GrantCommon Stock, $0.01 par value per share ("Common Stock") 260,869 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032076 · doc4.xml · nonDerivative · entry 1

Petras Michael B. Jr. · CIK 0001832387 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,869

F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on November 20, 2020, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in four equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.